Aizhida is a central nervous system stimulant indicated for the treatment of ADHD. Each once-daily capsule contains serdexmethylphenidate (SDX), a prodrug of dexmethylphenidate, c ...

Attention deficit hyperactivity disorder (ADHD) is a condition characterized by inattention, hyperactivity and impulsivity.

A new study has investigated how different medications and therapies compare with placebos in treating ADHD symptoms. Attention deficit hyperactivity disorder, or ADHD, was long thought to be a ...

Henry Shelford, chief executive of charity ADHD UK, warned that the dropping of shared care was dangerous for patients facing ...

German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...

Stimulant drugs that are widely used in the treatment of attention-deficit/hyperactivity disorder (ADHD) have a different ...

Children with attention-deficit/hyperactivity disorder who receive methylphenidate may be at an increased risk of having a ...

Medication and behavioral treatments are both widely used to treat ADHD. While medication is often the first-line treatment, patients who receive behavioral treatments—typically therapy, parent ...

Use of private providers, poor training and inadequate regulation mean obtaining care has become a ‘wild west’ ...

Lizzie Duszynski-Goodman is a journalist living in the Midwest with her husband and two young children. Her work explores the intersection of mental health, wellness and parenting. She is the former ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced that China's National Medical Products Administration ...